LON:PCGH

Polar Capital Glb Healthcare Interim Earnings Results & Report

GBX 460.99 -2.01 (-0.43%)
As of 04:10 AM Eastern

Polar Capital Glb Healthcare reported Interim earnings on May 29, 2026. The company reported EPS of GBX 1.41, while revenue was £2.38 million.

Earnings Announcement Details

Quarter
Interim
Report Date
Time
Before Market Opens

Polar Capital Glb Healthcare EPS Results

Actual EPS
GBX 1.41
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Polar Capital Glb Healthcare Revenue Results

Actual Revenue
£2.38 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Polar Capital Glb Healthcare Interim Earnings FAQ

Polar Capital Glb Healthcare (LON:PCGH) reported earnings of GBX 1.41 per share for Interim. The report was announced on Friday, May 29, 2026.

Polar Capital Glb Healthcare reported revenue of £2.38 million for Interim.

Polar Capital Glb Healthcare Earnings Headlines

Polar Capital Global Healthcare Trust Plc
My $247 scanner for $7
Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel
See More Polar Capital Glb Healthcare Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Polar Capital Glb Healthcare? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Polar Capital Glb Healthcare and other key companies, straight to your email.

About Polar Capital Glb Healthcare

Polar Capital Global Healthcare Trust plc (PCGH) made its debut on the London Stock Exchange in June 2010, raising £89m from a wide selection of investors. The Trust was launched as an opportunity to invest in the long-term growth appeal of the global healthcare sector, with a focus on large companies, particularly global pharmaceutical stocks. PCGH was a more cautious way to invest in the sector, with the Trust holding at least 80% in large, established companies and the freedom to invest across all subsectors globally. Up to 20% could be allocated to smaller, growth companies offering a higher risk/return profile. The subsectors the Trust looks at include healthcare services and healthcare technology, pharmaceuticals, healthcare equipment, biotechnology, life sciences tools and managed healthcare.

View Polar Capital Glb Healthcare Profile